Below are the Nasdaq 100 companies that are within 21% of the 52-week low. This list is strictly for the purpose of researching whether or not the companies have viable business models or are about to go out of business. These companies are deemed highly speculative unless otherwise noted.
| Symbol | Name | Trade | P/E | EPS (ttm) | Yield | P/B | % from Low |
|---|---|---|---|---|---|---|---|
|
Electronic Arts
|
16.06
|
N/A
|
-4.06
|
N/A
|
1.97
|
8.88%
|
|
|
Apollo Grp
|
59.22
|
14.25
|
4.16
|
N/A
|
6.23
|
12.18%
|
|
|
First Solar
|
115.10
|
15.34
|
7.50
|
N/A
|
3.94
|
14.07%
|
|
|
Stericycle
|
51.36
|
25.36
|
2.03
|
N/A
|
5.17
|
15.18%
|
|
|
Gilead Sci.
|
47.01
|
16.66
|
2.82
|
N/A
|
6.47
|
15.73%
|
|
|
Genzyme Corp.
|
55.73
|
31.77
|
1.75
|
N/A
|
1.93
|
18.35%
|
|
|
QUALCOMM
|
38.84
|
31.17
|
1.25
|
1.80%
|
2.98
|
19.00%
|
|
|
Pharma Product
|
21.65
|
13.70
|
1.58
|
2.80%
|
1.92
|
20.48%
|
|
|
Activision
|
11.11
|
45.35
|
0.25
|
1.40%
|
1.24
|
20.63%
|
Video game makers Electronic Arts (ERTS) and Activision (ATVI) seemed to be in a race to the bottom until ATVI announced that its earnings beat expectations and that they are going to pay a dividend for the first time. On the news, ATVI moved higher while ERTS continues to languish within 9% of a new low. However, the fact that ERTS is so low and isn't promoting "positive" news makes the company more attractive.
Pharamceutical Product Development (PPDI) is again edging back on to our new low list. As you'll note on my 2009 transaction overview, PPDI was one of my most successful ventures from the Nasdaq 100 Watch List. Although not yet a Dividend Achiever, the company has increased the dividend every year for 4 years in a row. The company has solid financials and carries no debt.
Apollo Group (APOL) has remained on the Watch List for 4 months now. Provided that APOL doesn't fall below the November lows, this company may be worth investigating. With return on assets around 25% and return on equity at around 50% it would be difficult to ignore this special situation. However, my primary concern would be on the issues of long-term debt and quality of reported earnings.
As a group, Genzyme (GENZ), Stericycle (SRCL), Gilead (GILD), and PPDI are all companies that I would invest in, to varying degrees. The healthcare sector, as well as the water utilities on the Dividend Achiever Watch List are demonstrating their relative undervaluation against the overall market.
-Touc